Unlock instant, AI-driven research and patent intelligence for your innovation.

Tumor-lysing virus growing selectively in tumor cells

An adenovirus and gene technology, applied in the field of oncolytic virus selectively proliferating in tumor cells, can solve the problems of low efficiency of gene introduction, unsatisfactory therapeutic effect, and inability to detect telomerase activity, etc.

Inactive Publication Date: 2008-11-05
ONCOLYS BIOPHARMA INC
View PDF3 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, in gene therapy, since a non-proliferative viral vector is used to introduce genes into diseased tissues, etc., considering the safety of the human body, it can only be used around the target cells
In addition, in the current gene therapy, due to the low efficiency of gene introduction, satisfactory therapeutic effect cannot be obtained
[0003] In cancerous cells or immortalized cell lines, the activity of telomerase increases in most cases. On the other hand, it is known that normal somatic cells other than germ cells, blood cell cells, epithelial stem cells, etc., almost Undetectable telomerase activity

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Tumor-lysing virus growing selectively in tumor cells
  • Tumor-lysing virus growing selectively in tumor cells
  • Tumor-lysing virus growing selectively in tumor cells

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0064]

[0065] Using specific primers (E1A-S: sequence 5, E1A-AS: sequence 6), RT-PCR was performed on the RNA extracted from 293 cells to amplify the 899bp E1A gene. The DNA extracted from 293 cells was subjected to DNA-PCR using primers (E1B-S: SEQ ID NO: 7, E1B-AS: SEQ ID NO: 8) to amplify the 1823 bp E1B gene.

[0066] The respective PCR products were subjected to TA cloning (TA cloning kit double promoter; Invitrogen), and after the sequence was confirmed, DNA fragments of 899 bp (E1A) and 1823 bp (E1B) were cut out by restriction enzyme EcoRI, respectively.

[0067] E1A and E1B (E1A-IRES-E1B) were respectively inserted in the forward direction at the M1uI cleavage site and the SalI site of the pIRES vector (CLONTECH).

[0068] The 455 bp hTERT promoter sequence cleaved with restriction enzymes M1uI and Bg1II was inserted forward into the XhoI site upstream of E1A of E1A-IRES-E1B (phTERT-E1A-IRES-E1B).

[0069] The cytomegalovirus (CMV) promoter contained in the pShut...

Embodiment 2

[0072]

[0073] Immortalized human vascular endothelial cells HUVEC, human normal fibroblasts ( In 10 kinds of cells of W138, NHLF), use RNAzol (Cinna / Biotecx) to extract RNA, use LightCycler and LightCycler DNA TeloTAGGG Kit (Roche Molecular Biochemicals), perform real-time quantitative reverse transcription (RT)-PCR, and compare the hTERT of each cell gene expression level. The result is shown in Figure 2.

[0074] Comparing A549 cells with the highest expression level as 1.0, it was confirmed that hTERT gene expression was 0.18 to 1.00 in A549, H226Br, H1299, SW620, DLD-1, LoVo and other cancer cells and 293 cells. However, in immortalized HuVEC cells Its expression was not detected in normal cells such as WI38 and NHLF.

Embodiment 3

[0076]

[0077] Human colorectal cancer cells SW620 and human normal fibroblasts WI38 were cultured in vitro, and RNA was recovered after 36 hours after infection with TRAD at concentrations of 0.1 and 1 MOI (multiplicity of infection). 293 cells were used as a positive control.

[0078] Reverse transcription (RT) was performed using the GeneAmp RNA PCR core kit, and the primers for the E1A and E1B genes were used for 30 cycles of amplification through the GeneAmp PCR system 9700 thermal cycler (PE Applied Biosystems). PCR products were electrophoresed on a 1.2% agarose gel and visualized by ethidium bromide staining (2 spots on Figure 3A). Band intensities were measured on a gel image analyzer and quantified and plotted using GAPDH as an internal standard (Fig. 3A bottom).

[0079] Human colorectal cancer cells SW620 and human normal fibroblasts WI38 were cultured in vitro, and the adsorbed cells were recovered after infecting TRAD at a concentration of 0.1 and 1 MOI for 4...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

By using a virus having a gene sequence comprising a telomerase promoter and an E1 gene (preferably a sequence comprising E1A gene, IRES sequence and E1B gene) or by using an anticancer agent comprising the virus, the virus replicates in cancer cells to thereby produce an efficient anticancer effect.

Description

technical field [0001] The present invention relates to a virus exhibiting an antitumor effect by proliferating in tumor cells, a polynucleotide contained in the virus, an anticancer agent containing the virus, and a method of treating cancer using the virus. Background technique [0002] Currently, gene therapy is one of the treatments for cancer. However, in gene therapy, because non-proliferative viral vectors are used to introduce genes into diseased tissues and other parts, considering the safety of the human body, they can only be used around target cells. In addition, in current gene therapy, satisfactory therapeutic effects cannot be obtained due to the low efficiency of gene introduction. [0003] In cancerous cells or immortalized cell lines, the activity of telomerase increases in most cases. On the other hand, it is known that normal somatic cells other than germ cells, blood cell cells, epithelial stem cells, etc., almost Telomerase activity could not be detec...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C12N15/09C12N7/01A61K48/00A61P35/00A61K35/76A61K35/761A61K38/00C07K14/075C12N7/00C12N9/12C12N15/861
CPCC12N9/1241A61K48/0058A61P35/00A61K48/00C12N7/00C12N15/09C12N15/11
Inventor 藤原俊义田中纪章京哲白木屋佳子川岛健
Owner ONCOLYS BIOPHARMA INC